Viewing Study NCT00034866


Ignite Creation Date: 2025-12-24 @ 4:16 PM
Ignite Modification Date: 2025-12-26 @ 10:47 PM
Study NCT ID: NCT00034866
Status: COMPLETED
Last Update Posted: 2005-09-20
First Post: 2002-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module